Table 2

CD8+ T cell reactivity to NY-ESO-1 HLA-A2-restricted peptides: Summary of tetramer, ELISPOT, and cytotoxicity assays

PatientTetramer*ELISPOT*Cytotoxicity
NY-ESO-1 mRNA-positive/Ab-positive
 NW14+++
 NW29+++
 NW516+++
 NW731+++
 NW37++
 NW977
NY-ESO-1 mRNA-positive/Ab-negative
 NW28
 NW33
 NW46
 NW315
 NW415
 NW681
 NW726
NY-ESO-1 mRNA-negative/Ab-negative
 NW30
 NW44
 NW45
 NW50
 NW51
  • *See footnotes in Table 1 and Fig. 4